跳至主要内容
临床试验/NCT04377321
NCT04377321已完成不适用

Colchicine Has Anti-diabetic Effect and May be an Option for Type 2 Diabetes Management

Ministry of Health and Population, Egypt1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年10月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
colchicine for treatment of type diabetes patients

研究概览

简要总结

Colchicine has antidiabetic effect and may be an option for type 2 diabetes management

详细描述

Observational cohort prospective study with following of 150 newly diagnosed type 2 diabetes patients who were in 3 groups, had been monitored in a private clinic, each group 50 patients number, with 30 females and 20 males after written consent from all patients. The ages of all patients were between 35 and 55 years.

The aim of this study was to evaluate colchicine effect on A1C of newly diagnosed type2 diabetes compared to the metformin and control group on diet only.

The first group patients received colchicine 0.5twice daily for 6 months, the second group received metformin 1gm twice daily, the third group patients were on diet only. During the period of treatment, the investigators followed the patients if there were side effects of the drugs used. No side effects were monitored during the period of treatment except for gastric upset in some patients using metformin

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • type 2 diabetes newly diagnosed age 35- 55 years

排除标准

  • severe anemia hypothyroidism and hyperthyroidism moderate to severe liver or kidney disease

研究组 & 干预措施

group 1 on cochicine

The first group patients received colchicine 0.5 twice daily for 6 months

干预措施: Colchicine Tablets (Drug)

group 2 on glucophage 1 gm twice daily

second group received glucophage 1gm twice daily for 6 months

干预措施: Colchicine Tablets (Drug)

group 3 control

the third group patients were on diet only for 6 months

干预措施: Colchicine Tablets (Drug)

结局指标

主要结局

colchicine for treatment of type diabetes patients

时间窗: 6 months

colchicine tablets .5 mg twice daily for 6 months

次要结局

未报告次要终点

研究者

发起方
Ministry of Health and Population, Egypt
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

mahmoud younis

consultant

Ministry of Health and Population, Egypt

研究点 (1)

Loading locations...

相似试验